Skip to main content

Rheumatoid Arthritis

Roundup RHeum ACR
The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020. Watch now!
Rheumatology Round-Up with Drs. Kavanaugh & Cush

The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020.

RT @RHEUMarampa: Tofa for RA by the grp of Dr. Atul Deodhar:
>Tofa(56%) vs. pbo(29.4%)-significant improvement in AS

sheila RHEUMarampa

3 weeks 4 days ago
Tofa for RA by the grp of Dr. Atul Deodhar: >Tofa(56%) vs. pbo(29.4%)-significant improvement in ASAS20 at wk 16 >Primary & secondary endpts met >No new safety signals reported @Rheumnow #ACR20 https://t.co/G9U5cCQU7K
A Review of RA Studies at ACR: Dr. Janet Pope

Dr. Janet Pope reviews #0483, #0187, #1715, #0151 and #1736 presented at the 2020 ACR annual meeting.

Lifestyle and Risk of RA, Lupus: Dr. Janet Pope

Dr. Janet Pope reviews abstracts #1198 and #1473 presented at the 2020 ACR annual meeting.

steroids.prednisone.pills_.jpg
During Monday’s release of the new ACR 2020 Pharmacologic Treatment Recommendations for the Management of Rheumatoid Arthritis, many practitioners were surprised that the new guidelines recommended…
New ACR RA Guidelines and Practice Changing Abstracts: RA Panel

Dr. Jonathan Kay leads an international panel on the new ACR RA guidelines and other practice-changing abstracts presented at the 2020 ACR annual meeting. Panelists include Dr.Kathryn Dao, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway and Dr. Sheila Reyes. 

Dr. Jonathan Kay leads an international panel of rheumatologists to elicit their opinions on key abstracts at #ACR20. Pa

Dr. John Cush RheumNow

3 weeks 4 days ago
Dr. Jonathan Kay leads an international panel of rheumatologists to elicit their opinions on key abstracts at #ACR20. Panelists: @drdavidliew, @ejdein1, @MeralElRamahiMD, @RichardPAConway, @RHEUMarampa, and @jeffsparks https://t.co/btZKgwvoSn https://t.co/Okdvx9HuNc
Cardiovascular Risk on MTX in Rheumatoid Arthritis: Dr. Jonathan Kay

Dr. Jonathan Kay reviews several studies that look at the cardiovascular risk of methotrexate in people with rheumatoid arthritis. 

Vaccination with Shingrix: Does it work for patients on JAKi?

Dr. Jeffrey Curtis examines abstracts #1997 and #0452 presented at the ACR 2020 annual meeting.

×